COGNOSCI, INC.

Biotech · Private

Novel prodrug molecules based on DFMO that inhibit ornithine decarboxylase to reduce polyamines in the brain for Alzheimer's disease treatment

Grants
$450K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
8
2 granted · 6 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Antagonizing the SET Oncoprotein$225,000
Federal grantDepartment of Health and Human Services · Phase I · Novel Orally-Available Prodrugs for Alzheimer's Disease$225,000
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2712ENCUE INC.——
2713Immune Response BioPharma, Inc.—$1.0B
2714Foghorn Therapeutics——
2715COGNOSCI, INC.——
2716IMPLICYTE, INC.——
2717OnRamp Digital, Inc.—$360K
2718Mendra——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 8
  • Apoe Peptide Dimers And Uses Thereofgranted
  • Apoe Peptide Dimers And Uses Thereofgranted
  • Methods Of Treating Cancer With Apoe Peptidesapplication
  • Methods Of Inhibiting Calcineurin With Apoe Analogsapplication
  • Methods For Modulating Set And Uses Thereofapplication
  • Improved Apo E Analogs And Methods For Their Useapplication
  • Methods Of Suppressingmicroglial Activation And Systemic Inflammatory Responsesapplication
  • Apoe Peptide Dimers And Uses Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.